HealthStream, Inc.

HealthStream, Inc. (HSTM) Market Cap

HealthStream, Inc. has a market capitalization of $819.2M.

Price: $28.04

-0.16 (-0.57%)

Market Cap: 819.19M

NASDAQ · time unavailable

CEO: Robert A. Frist Jr.

Sector: Healthcare

Industry: Medical - Healthcare Information Services

IPO Date: 2000-04-11

Website: https://www.healthstream.com

HealthStream, Inc. (HSTM) - Company Information

Market Cap: 819.19M|Sector: Healthcare

Company Profile

HealthStream, Inc., established in 1990 and headquartered in Nashville, Tennessee, delivers specialized workforce and provider solutions to healthcare organizations throughout the United States. Its operations are divided into two primary segments: Workforce Solutions and Provider Solutions. The Workforce Solutions segment provides a suite of software-as-a-service (SaaS) and subscription-based tools. These comprehensive services address various aspects of healthcare staff development and management, encompassing clinical skill enhancement, talent acquisition and retention, training programs, educational resources, professional certification, scheduling logistics, competency evaluations, and performance reviews. Additionally, this segment offers support through implementation and account management. Specific applications under this umbrella cover learning platforms, performance assessment, competency tracking, disclosure management, clinical skill evaluation, simulation-based learning, quality assurance, and sector-specific training. Complementing this, the Provider Solutions segment focuses on administrative and operational needs. It includes VerityStream, an enterprise platform designed to optimize the experience for healthcare providers across diverse settings such as ambulatory surgery centers, urgent care clinics, medical groups, and other facilities. Furthermore, HealthStream offers EchoCredentialing and MSOW platforms to streamline the credentialing, enrollment, and privileging processes for medical staff in hospitals. EchoOneApp facilitates provider enrollment for medical groups. Other key offerings comprise CredentialMyDoc, a SaaS solution for credentialing and enrollment for medical groups and surgery centers; CredentialStream, another SaaS-based platform for provider credentialing, privileging, and enrollment; and NurseGrid Mobile, a dedicated application for nurse managers. These diverse solutions are marketed directly to a broad spectrum of healthcare entities, including private, non-profit, and governmental organizations, as well as pharmaceutical and medical device manufacturers.

Analyst Sentiment

63%
Buy

From 5 Active Polls

1Y Forecast: $27.00

▼ -3.7% Potential Upside

Consensus Target Metrics

Low Bound

$27

Median

$27

High Bound

$27

Average

$27

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$27.00
▼ -3.71% Upside
Low Target
$27.00
-4% Risk
Median Target
$27.00
-4% Mid
High Target
$27.00
-4% Max
Consensus
Hold
7 / 16 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)819608683859839980967877838
Enterprise Value ($M)785574662821803919928837811
Price to Earnings Ratio (P/E)42.1325.8967.3835.3038.4357.4649.6937.9549.23
Price/Earnings-to-Growth Ratio (PEG)13.8015.9312.6431.0031.8617.64
Price to Sales Ratio (P/S)2.637.498.5711.2411.2813.3313.0312.0011.71
Price to Book Ratio (P/B)2.341.731.932.462.392.702.692.472.40
Price to Free Cash Flow Ratio (P/FCF)15.3730.9352.6147.95310.0337.6588.3071.46133.49
Enterprise Value to Sales (EV/Sales)7.078.3010.7410.7912.5112.5011.4611.33
Enterprise Value to EBITDA (EV/EBITDA)11.2329.9147.6643.0545.2757.4358.2047.7151.74
Debt to Equity Ratio-0.500.040.040.040.050.050.060.050.05

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 HEALTHSTREAM INC (HSTM) — Investment Overview

🧩 Business Model Overview

HealthStream provides technology-enabled learning, talent management, and performance improvement solutions to healthcare organizations. The value chain centers on (1) delivering clinical and compliance training content, assessments, and credentials; (2) enabling administrators to manage training assignments, reporting, and workforce development workflows; and (3) using performance and completion data to support quality, staffing, and operational improvement initiatives within health systems.

The commercial model is built around embedding into the daily HR and education operating cadence of hospitals and health networks—creating administrative dependency on recurring training administration, learner tracking, and reporting outputs.

💰 Revenue Streams & Monetisation Model

Revenue is predominantly recurring and subscription-oriented, driven by customer access to the platform, user/seat-based services, and ongoing training content libraries. Monetisation is supported by:

  • Subscription/managed access revenue: platform usage for onboarding, mandatory training, compliance, and continuing education administration.
  • Content and assessment enablement: recurring delivery of training modules, performance tools, and credentialing-related services.
  • Talent/performance workflow services: technology and program components that extend beyond training into workforce development and performance measurement.

Margin drivers are tied to the software/content mix and the cost discipline around content development, hosting, and customer support. As the customer base scales, gross margin is typically supported by the repeatable nature of platform delivery, while operating leverage depends on maintaining disciplined sales and customer success investment amid healthcare procurement cycles.

🧠 Competitive Advantages & Market Positioning

HealthStream’s core moat is switching costs plus workflow integration and data gravity. Once a healthcare organization standardizes on HealthStream for compliance training, skills development, and internal reporting, the platform becomes embedded into HR/L&D processes. Migration requires re-implementing learning plans, rebuilding historical training records and reporting frameworks, retraining administrators, and re-establishing vendor relationships for content and assessments—costs that are both operational and timing-related.

Additional defensibility comes from healthcare-specific content depth and the need for continual updates to training requirements. In regulated environments, buyers prefer providers with established content credibility and operational familiarity.

  • Relias: competes primarily on healthcare learning and compliance platforms, targeting health systems seeking enterprise training administration and content breadth.
  • Traliant: focused on compliance and learning solutions with emphasis on risk and policy training delivery.
  • Wolters Kluwer: serves healthcare and professional audiences with compliance and information products, competing for training and regulatory-adjacent budget lines.

Compared with these rivals, HealthStream’s positioning emphasizes an integrated set of learning and talent/performance capabilities tailored to healthcare workforce needs, strengthening buyer stickiness through entrenched workflows and the long-lived nature of training administration data.

🚀 Multi-Year Growth Drivers

  • Digitization of healthcare workforce development: ongoing shift from paper- and instructor-led compliance toward scalable online learning administration.
  • Rising compliance and documentation expectations: healthcare providers face expanding scrutiny on training completion, credentialing readiness, and auditability, which increases demand for robust reporting workflows.
  • Workforce churn and labor constraints: organizations invest in repeatable onboarding and continuing education to manage turnover and standardize competency.
  • Quality and performance management tie-ins: learning platforms increasingly support broader performance improvement initiatives through structured competency frameworks and measurement.
  • TAM expansion across care settings: growth opportunities extend beyond large acute care systems into broader provider networks and ambulatory/long-term care environments where standardized training administration is increasingly valued.

Over a 5–10 year horizon, durable growth is most likely to come from net customer additions and expansion within existing accounts—leveraging the platform’s embedded nature and the repeatable economics of subscription renewals.

⚠ Risk Factors to Monitor

  • Procurement and budget cyclicality: healthcare buyers can slow software spending during cost pressures, affecting new customer conversion and expansion pacing.
  • Competitive displacement: enterprise healthcare learning is crowded; larger content and software players can pursue account consolidation by bundling adjacent HR/compliance solutions.
  • Technology integration risk: reliance on customer administrative workflows increases the importance of integration quality with HR systems and related data sources.
  • Content relevance and maintenance: the value proposition depends on timely, accurate, healthcare-appropriate training content and assessment coverage.
  • Cybersecurity and data privacy: learner and HR-related data increase the operational consequences of security incidents and require sustained investment.

📊 Valuation & Market View

The market generally values healthcare software and recurring learning platforms on a blend of revenue durability and operating leverage. Key valuation sensitivities typically include:

  • Recurring revenue visibility: subscription mix and renewal strength.
  • Retention and expansion: account growth through additional modules, talent/performance tools, and increased user penetration.
  • Margin profile: gross margin sustainability driven by scale economics and content delivery efficiency.
  • Sales efficiency: effectiveness of customer acquisition and conversion in a fragmented healthcare buying landscape.

Sector investors often look for evidence that platform adoption can compound over time—turning training administration into a broader workforce-development workflow relationship.

🔍 Investment Takeaway

HealthStream’s investment case rests on healthcare-specific workflow embedding that creates durable switching costs and data gravity around learning and workforce development administration. While competition is active from specialized compliance learning providers and broader compliance/content vendors, the operational burden of migration and the auditability/reporting needs of healthcare organizations support a long-lived recurring revenue foundation. The multi-year opportunity is tied to continued digitization of compliance and talent development across provider networks, with upside from deeper account expansion where the platform becomes the system of record for workforce training and performance-related processes.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for HSTM.

gurufocus.com2026-07-23

HealthStream to Host Second Quarter 2026 Earnings Conference Call

HealthStream, Inc. (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, announced today that it will host a confer

businesswire.com2026-07-23

HealthStream to Host Second Quarter 2026 Earnings Conference Call

NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthStream, Inc. (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, announced today that it will host a conference call and webcast to discuss its second quarter 2026 financial results on Tuesday, August 4, 2026. The Company's financial results for the second quarter 2026, ended June 30, 2026, will be released after the routine time for the close of the market on Monday, August 3, 2026.HealthStream's second quar.

zacks.com2026-07-10

HSTM or SIFY: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Internet - Services sector have probably already heard of HealthStream (HSTM) and Sify Technologies Limited (SIFY). But which of these two companies is the best option for those looking for undervalued stocks?

zacks.com2026-07-08

HealthStream, Inc. (HSTM) Hits Fresh High: Is There Still Room to Run?

HealthStream (HSTM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

zacks.com2026-06-17

HSTM or SIFY: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Internet - Services sector might want to consider either HealthStream (HSTM) or Sify Technologies Limited (SIFY). But which of these two stocks presents investors with the better value opportunity right now?

zacks.com2026-06-01

HSTM vs. SIFY: Which Stock Is the Better Value Option?

Investors interested in stocks from the Internet - Services sector have probably already heard of HealthStream (HSTM) and Sify Technologies Limited (SIFY). But which of these two stocks is more attractive to value investors?

zacks.com2026-05-15

HSTM or SIFY: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Internet - Services sector have probably already heard of HealthStream (HSTM) and Sify Technologies Limited (SIFY). But which of these two stocks is more attractive to value investors?

seekingalpha.com2026-05-05

HealthStream, Inc. (HSTM) Q1 2026 Earnings Call Transcript

HealthStream, Inc. (HSTM) Q1 2026 Earnings Call Transcript

zacks.com2026-05-04

HealthStream (HSTM) Q1 Earnings and Revenues Surpass Estimates

HealthStream (HSTM) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.14 per share a year ago.

businesswire.com2026-05-04

HealthStream Announces First Quarter 2026 Results

NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthStream, Inc. (the "Company") (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, today announced results for the first quarter ended March 31, 2026. First Quarter 2026 Revenues of $81.2 million, up 10.5% from $73.5 million in the first quarter of 2025, setting a new Company record for quarterly revenue Operating income of $7.5 million, up 71.6% from $4.4 million in the first quarter of 2025 Net income of $5.

businesswire.com2026-04-21

HealthStream to Host First Quarter 2026 Earnings Conference Call

NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthStream, Inc. (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, announced today that it will host a conference call and webcast to discuss its first quarter 2026 financial results on Tuesday, May 5, 2026. The Company's financial results for the first quarter 2026, ended March 31, 2026, will be released after the routine time for the close of the market on Monday, May 4, 2026. HealthStream's first quarter 20.

businesswire.com2026-03-26

Virsys12® Named a Leader in the IDC MarketScape: U.S. Provider Data Management for Payers 2025–2026 Vendor Assessment

NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthStream® (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, announced today that Virsys12® has been recognized as a Leader in the IDC MarketScape: U.S. Provider Data Management for Payers 2025–2026 Vendor Assessment (Doc #US52986825, December 2025). Virsys12 and its V12 Enterprise® Suite offer payers and health plans an innovative provider data management suite used for onboarding, credentialing, and network.

defenseworld.net2026-03-14

HealthStream (NASDAQ:HSTM) to Buyback $10.00 million in Outstanding Stock

HealthStream (NASDAQ: HSTM - Get Free Report) announced that its Board of Directors has initiated a share repurchase plan on Friday, March 13th, RTT News reports. The company plans to buyback $10.00 million in outstanding shares. This buyback authorization authorizes the technology company to reacquire up to 1.7% of its shares through open market purchases. Shares

businesswire.com2026-03-13

HealthStream Announces Share Repurchase Program

NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthStream (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, today announced that its Board of Directors has approved a new share repurchase program for the Company's common stock, under which the Company may repurchase up to $10 million of outstanding shares of common stock. Pursuant to the authorization, repurchases may be made from time to time in the open market, including under Rule 10b5-1 plans, through.

defenseworld.net2026-03-09

Intech Investment Management LLC Sells 52,995 Shares of HealthStream, Inc. $HSTM

Intech Investment Management LLC decreased its stake in HealthStream, Inc. (NASDAQ: HSTM) by 63.8% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 30,115 shares of the technology company's stock after selling 52,995 shares during the period. Intech Investment Management

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"Headline (2026-03-31, Q1): Revenue $81.2M (+1.8% QoQ; +10.5% YoY). Net income $5.91M (+133.3% QoQ; +36.4% YoY). EPS was $0.20 (vs $0.086 QoQ; $0.14 YoY). Profitability improved: gross margin expanded to 65.8% (from 63.8% QoQ and 65.3% YoY), and net margin rose to 7.3% (from 3.2% QoQ; 5.9% YoY). Over the quarter, operating income increased to $7.5M (operating margin 9.3% vs 3.0% QoQ). Expense discipline appears to be improving—operating expenses were $45.9M, lower than Q4’s $48.5M despite higher revenue. Cash flow quality looks solid for a single quarter: operating cash flow was $27.1M and free cash flow was $26.4M, supporting shareholder payouts (dividends of ~$1.0M) alongside modest buybacks (repurchased ~$6.7M shares). Balance sheet resilience remains good: total assets were $527.4M, with equity at $352.0M; leverage is low (net debt negative at about -$34.6M). However, total shareholder returns are pressured—market price is down 33.1% over the past 1 year, with only a minimal dividend yield (~0.17%), so capital appreciation has not supported returns."

Revenue Growth

Positive

Q1 revenue rose to $81.2M (+1.8% QoQ from $79.7M) and +10.5% YoY (vs $73.5M in Q1’25), indicating steady demand.

Profitability

Good

Net income grew to $5.91M (+133.3% QoQ; +36.4% YoY). Net margin expanded to 7.3% (from 3.2% QoQ; 5.9% YoY) and gross margin improved to 65.8%.

Cash Flow Quality

Positive

Q1 operating cash flow was $27.1M and free cash flow $26.4M, converting earnings into cash well. Dividends paid (~$1.0M) were modest and covered by FCF; buybacks continued (~$6.7M).

Leverage & Balance Sheet

Good

Low leverage with negative net debt (~-$34.6M). Equity was stable at $352.0M and total assets increased modestly vs Q4.

Shareholder Returns

Neutral

1-year price change is -33.1% and dividend yield is only ~0.17%, implying total shareholder return has been dominated by capital depreciation despite buybacks.

Analyst Sentiment & Valuation

Fair

Valuation appears expensive on earnings/FCF metrics (e.g., P/E ~25.7; P/FCF ~23.0). Consensus target is $25 vs current ~$21.73, suggesting limited upside.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

HealthStream delivered a strong Q1 2026 performance led by mix-driven margin expansion and continued share gains in credentialing and scheduling. Revenues rose 10.5% to $81.2M and record adjusted EBITDA rose 24.1% to $20.1M, with adjusted EBITDA margin expanding 280 bps to 24.8%. Gross margin increased 50 bps to 65.8%, but management emphasized it was largely revenue mix and timing rather than structural improvement. Growth catalysts were Competency Suite (+17.3%), Resuscitation Suite content updates tied to ILCOR science, CredentialStream (+~19%) via customer expansions and payer-market entry (Verisys (Versus)12), and ShiftWizard (+~29%) competitive takeouts including a ~10k-employee system. Key headwind is legacy application revenue decline (~16%–17% YoY). Management reaffirmed FY 2026 guidance and guided Q2 revenue growth ~9.5% with adjusted EBITDA margin ~23%, while front-loading Career Networks sales and My Clinical Exchange technology investments.

AI IconGrowth Catalysts

  • Learning: Competency Suite revenue up 17.3% (bundle subscriptions with unlimited use for applicable employees)
  • Learning content: American Red Cross Resuscitation Suite delivered 18 updated courses aligned to new ILCOR science guidelines in a single-day deployment
  • Learning/credentialing: CredentialStream revenues up ~19% YoY; two large CredentialStream expansions tied to M&A and enterprise-wide standardization
  • Credentialing expansion: Verisys (Versus)12 contributing among top-three credentialing wins; extending into payer credentialing
  • Scheduling: ShiftWizard revenues up ~29% YoY; takeout wins from a competitor focused outside healthcare; more medium-large wins including a ~10k-employee system
  • Career networks scale: Career Networks contributed ~$3.78M in the quarter; continued growth in hStream IDs and network effect

Business Development

  • Cedars-Sinai Medical Center: renewed/expanded Resuscitation Suite users by 50%; expansion linked to being named official medical provider for the 2028 LA Olympic and Paralympic Games
  • Verisys (Versus)12: post-acquisition contribution cited as top-three credentialing wins; payer credentialing market expansion
  • MissionCare Collective and Verisys (Versus)12: Q1 inorganic revenue contributions referenced as part of 2025 acquisitions
  • My Clinical Exchange: connected 715 health organizations and 1.9k schools to clinical placements; used by 450k+ hStream IDs created through career networks

AI IconFinancial Highlights

  • Record revenues: $81.2M (+10.5% YoY); record adjusted EBITDA: $20.1M (+24.1% YoY); operating income +71.6% YoY
  • EPS: $0.20 vs $0.14 YoY (+42.9% YoY implied), driven by higher profitability
  • Gross margin: 65.8% vs 65.3% YoY (+50 bps); management attributed to revenue mix, timing of activations, and consumption-based revenue pulled forward
  • Adjusted EBITDA margin: 24.8% vs 22.0% YoY (+280 bps); partly mix-driven
  • Revenue composition: subscription revenues +10.7% (+$7.6M); professional services +4.3% (+$0.1M)
  • Organic vs inorganic: organic growth 5.8%; inorganic growth 4.7% (acquisitions: Verisys (Versus)12 and MissionCare Collective)
  • Legacy drag: legacy credentialing/scheduling revenue approximated $7.6M and declined ~16% YoY (management noted ongoing attrition even while some revenue migrates into CredentialStream and ShiftWizard)
  • Performance obligations: $687M remaining vs $613M prior-year period end; ~39% to convert in 12 months, 67% in 24 months
  • Cash flows: operating cash flow $27.1M; free cash flow $19.7M (+7.9% YoY); DSO 39 days (vs 37 days prior year); maintained objective 40–45 days or better

AI IconCapital Funding

  • Cash/investments: $66.5M end of quarter vs $57M prior quarter; no long-term debt and untapped line of credit referenced
  • Capex: $7.5M in Q1 (vs $8.8M prior year); 2026 capex guidance $31M–$34M
  • Share repurchases: $7.5M in Q1 under existing programs; $2.5M under the March 2026 $10M authorization; program terminates earlier of Sep 12, 2026 or when fully expended
  • Dividends: $0.035 per share declared; paid May 29, 2026 to holders of record May 18, 2026
  • Minority investments: $1.8M into companies expected to leverage ecosystem/platform

AI IconStrategy & Ops

  • AI: internal role expanded; broad adoption across teams with early productivity/quality benefits; hStream built to incorporate AI as core infrastructure (hStream ID, growing API footprint)
  • Cloud transition: management noted potential future gross-margin compression as cloud initiatives mature (no significant gross margin lift expected beyond mix in Q1)
  • Investments front-loaded into Career Networks: sales organization expanded after Q1; plans to build Career Networks sales in first half (especially Q2)
  • Technology infrastructure build: increased planned investments in tech stack for acquired product My Clinical Exchange; more CapEx/OpEx to enhance application/platform
  • Migration strategy: continued migration of legacy application customers into newer CredentialStream and ShiftWizard; legacy bucket still declining

AI IconMarket Outlook

  • Reaffirmed FY 2026 guidance: revenue $323M–$330M; net income $20.4M–$22.8M; adjusted EBITDA $73M–$77M
  • Q2 outlook: revenue growth rate ~9.5%; adjusted EBITDA margin ~23%
  • 2026 capex guidance: $31M–$34M
  • Remaining performance obligation conversion expectations: ~39% in next 12 months; ~67% in next 24 months

AI IconRisks & Headwinds

  • Legacy revenue attrition: legacy credentialing/scheduling revenue down ~16% YoY in Q1 with ongoing attrition despite migration efforts
  • Gross margin profile: management does not expect annual gross-margin improvement; potential margin compression as cloud migration progresses
  • Revenue timing/mix: Q1 margin outperformance described as revenue mix and pull-forward of activations/consumption-based revenue, implying less repeatability
  • Macro/workforce dynamics (implied): AI-driven efficiency could create CFO concern about staffing needs, but management cited nurse shortage with demand outpacing supply

Q&A: Analyst Interest

  • Gross margin durability and margin drivers: Management said Q1’s 65.8% gross margin was slightly ahead due to revenue mix and timing (activations pulled forward, consumption-based revenue). They do not anticipate a significant additional gross margin lift in Q2. Over time, cloud transitions could compress margins.
  • Acquisitions annualization, legacy drag, and EBITDA cadence: Management referenced targeting about $13M full-year acquisition contribution already stated last quarter, with Q1 possibly slightly ahead due to annualization timing. Legacy application revenue was ~$7.6M, down ~16%–17%, with ongoing attrition. Investments for Career Networks sales and My Clinical Exchange tech stack aim to change EBITDA cadence.
  • ShiftWizard competitive takeouts and bundling momentum: Management said takeouts reflect healthcare-specific vertical focus, including a ~10,000-employee system win; wins skewed larger-to-medium health systems. For bundling, they cited uptake in small hospital/critical access and skilled nursing/long-term care bundles, while larger Competency Suite bundles drove broader growth.

Sentiment: MIXED

Note: This summary was synthesized by AI from the HSTM Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for HSTM.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (HSTM)

© 2026 Stock Market Info — HealthStream, Inc. (HSTM) Financial Profile